Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-menthol for Breathlessness in COPD
NCT05888597Phase 2Completed
- Sponsor
- Region Skåne
- Start
- May 2023
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in chronic obstructive pulmonary disease (COPD) comparing Menthol with Placebo (2 arms). Primary endpoint: Breathlessness intensity up to 1 year. Started May 2023; status: completed.
02
Drugs
l-Menthol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT05888597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05888597.